Pharmaceuticals
-
Monoclonal antibody offers migraine hope
A monoclonal antibody offers a promising treatment for migraine, German researchers are to tell a major conference. Read more
-
New drug targets for prostate cancer
Landmark research into prostate cancer has revealed 80 molecular ‘weaknesses’ that could be targeted by drugs, it was announced last night. Read more
-
New drug class unveiled at Imperial
British researchers have announced the development of a new class of drug developed to treat drug-resistant tumours. Read more
-
Mixed-drug approach to malaria
A drug used to treat parasitic diseases is also effective at controlling mosquitoes, British researchers report today. Read more
-
RA drug reduces inflammation in stroke patients
People in the early stages of a stroke have benefitted from an anti-inflammatory drug normally used for rheumatoid arthritis, a new research has found. Read more
-
Drug reduces progression in secondary progressive MS
The progression of disability in secondary progressive multiple sclerosis can be slowed down with a new drug, researchers report today. Read more
-
Targeted drugs beneficial to HER2 positive patients
Women with HER2 positive breast cancer could avoid having extensive surgery involving mastectomy and removal of several lymph nodes by receiving targeted drugs before surgery, leading oncologists have heard. Read more
-
Complementary GPs reduce antibiotic use
GPs who have training in complementary therapies enjoy some success in limiting use of antibiotics, according to an analysis published today. Read more
-
Hope for menopause treatment
Rapid results are being seen with a new medication to treat uncomfortable symptoms caused by the menopause. Read more
-
Drink rather than vaccine may be cholera answer
A fast-acting, drinkable antidote for cholera epidemics is getting closer to being developed, according to two new studies. Read more
